223 related articles for article (PubMed ID: 34426483)
21. Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report.
Sriratanaviriyakul N; Nguyen LP; Henderson MC; Albertson TE
J Med Case Rep; 2014 Oct; 8():332. PubMed ID: 25297051
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
[TBL] [Abstract][Full Text] [Related]
23. Dress syndrome in 7-year-old male child - case report.
Prylińska M; Dworakowska-Kicińska M; Krogulska A
J Mother Child; 2021 Jan; 24(3):45-48. PubMed ID: 33470957
[TBL] [Abstract][Full Text] [Related]
24. A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature.
Zhang Y; Wang X; Cheng Y; Wang X; Zhang Y
BMC Pulm Med; 2022 Jul; 22(1):279. PubMed ID: 35854287
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of add-on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome.
Sim DW; Yu J; Koh YI
Clin Transl Sci; 2022 Mar; 15(3):782-788. PubMed ID: 34796665
[TBL] [Abstract][Full Text] [Related]
26. DRESS syndrome: a detailed insight.
Behera SK; Das S; Xavier AS; Selvarajan S
Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
[TBL] [Abstract][Full Text] [Related]
27. Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.
Rubin L; Talmon A; Ribak Y; Kessler A; Martin Y; Haran TK; Shamriz O; Adini I; Tal Y
Front Immunol; 2023; 14():1134178. PubMed ID: 37187735
[TBL] [Abstract][Full Text] [Related]
28. Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center.
Schroeder JW; Napoli C; Caputo V; Bonoldi E; Rongioletti F
Clin Dermatol; 2023; 41(6):721-728. PubMed ID: 37730074
[TBL] [Abstract][Full Text] [Related]
29. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692
[TBL] [Abstract][Full Text] [Related]
30. Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Caused by Itraconazole in a 17-Year-Old Girl.
Pires Pereira H; Coutinho IA; Carrapatoso I; Todo-Bom A
Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):143-146. PubMed ID: 37729075
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine-associated DRESS syndrome: A case report.
Bayram E; Toyran T; Paydas S
J Oncol Pharm Pract; 2023 Sep; 29(6):1480-1483. PubMed ID: 37006201
[TBL] [Abstract][Full Text] [Related]
32. Clinical, biochemical, and serologic predictors of drug reaction with eosinophilia and systemic symptoms syndrome: A prospective case-control study.
Choudhary R; Vinay K; Srivastava N; Bishnoi A; Kamat D; Parsad D; Bhatia A; Kumaran MS
J Am Acad Dermatol; 2021 Oct; 85(4):901-909. PubMed ID: 33785387
[TBL] [Abstract][Full Text] [Related]
33. Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report.
Wang L; Li LF
Medicine (Baltimore); 2017 Mar; 96(11):e6346. PubMed ID: 28296768
[TBL] [Abstract][Full Text] [Related]
34. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
[TBL] [Abstract][Full Text] [Related]
35. Toxocarosis and putative DRESS syndrome in an oncological patient: a case report.
Wutte N; Palfner M; Auer H; Ruckenbauer G; Valentin T; Seeber K; Aberer W; Krause R; Hoenigl M
Wien Klin Wochenschr; 2014 Apr; 126 Suppl 1():S51-5. PubMed ID: 24249317
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.
Blumenthal KG; Alvarez-Arango S; Fu X; Kroshinsky D; Choi H; Phillips E; Zhou L
JAMA Dermatol; 2022 Dec; 158(12):1449-1453. PubMed ID: 36322078
[TBL] [Abstract][Full Text] [Related]
37. A Young Child with Eosinophilia, Rash, and Multisystem Illness: Drug Rash, Eosinophilia, and Systemic Symptoms Syndrome After Receipt of Fluoxetine.
Vignesh P; Kishore J; Kumar A; Vinay K; Dogra S; Sreedharanunni S; Prasun Giri P; Pal P; Ghosh A
Pediatr Dermatol; 2017 May; 34(3):e120-e125. PubMed ID: 28523892
[TBL] [Abstract][Full Text] [Related]
38. Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital.
Brizendine CE; Naik PJ
Am J Health Syst Pharm; 2013 Mar; 70(6):507-10. PubMed ID: 23456403
[TBL] [Abstract][Full Text] [Related]
39. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
[TBL] [Abstract][Full Text] [Related]
40. Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Hagiya H; Iwamuro M; Tanaka T; Hasegawa K; Hanayama Y; Kimura M; Otsuka F
Intern Med; 2016; 55(13):1769-74. PubMed ID: 27374681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
